Precision Biosciences (DTIL) Total Liabilities (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Total Liabilities data on file, last reported at $67.8 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $67.8 million, down 9.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.8 million (down 9.7% YoY), and the FY2025 annual result was $62.2 million, down 22.29% from the prior year.
• Total Liabilities advanced to $67.8 million in Q1 2026 per DTIL's latest filing, from $62.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $194.1 million in Q2 2022 and troughed at $62.2 million in Q4 2025.
• A 5-year average of $119.0 million and a median of $111.7 million in 2022 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 49.84% in 2022, then tumbled 49.11% in 2025.
• A 5-year view of Total Liabilities shows it stood at $177.7 million in 2022, then dropped by 20.71% to $140.9 million in 2023, then plunged by 43.23% to $80.0 million in 2024, then slipped by 22.29% to $62.2 million in 2025, then increased by 9.04% to $67.8 million in 2026.
• Business Quant data shows DTIL's Total Liabilities at $67.8 million in Q1 2026, $62.2 million in Q4 2025, and $76.9 million in Q3 2025.